XML 25 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net (loss) income $ (31,882) $ (3,048)
Adjustments to reconcile net (loss) income to net cash provided by    
Depletion, depreciation and accretion 52,926 56,624
Impairment of contract asset 18,511  
Stock-based compensation, net 152 (1,070)
Unrealized gain on derivative contracts (11,116) (21,934)
Amortization/accretion of financing related costs 6,418 7,615
Loss (gain) on extinguishment of debt 7,489  
Accrued settlements on derivative contracts 403 259
Change in fair value of embedded derivative liability (2,084) (2,052)
Other expense (income) 324 358
Change in assets and liabilities:    
Accounts receivable (2,765) 15,658
Prepaids and other (75) 202
Accounts payable and accrued liabilities (2,946) (35,023)
Net cash provided by operating activities 35,355 17,589
Cash flows from investing activities:    
Oil and natural gas capital expenditures (64,625) (46,288)
Proceeds received from sales of oil and natural gas assets 7,015 4,929
Acquisition of oil and natural gas properties (47)  
Other operating property and equipment capital expenditures (23) (153)
Contract asset (7,737) (10,308)
Other (26) (25)
Net cash used in investing activities (65,443) (51,845)
Cash flows from financing activities:    
Proceeds from borrowings 162,000  
Repayments of borrowings (200,109) (35,093)
Payment of deferred financing costs (8,400)  
Proceeds from issuance of preferred stock 38,781 94,607
Other   (455)
Net cash (used in) provided by financing activities (7,728) 59,059
Net increase (decrease) in cash, cash equivalents and restricted cash (37,816) 24,803
Cash, cash equivalents and restricted cash at beginning of period 57,619 32,816
Cash, cash equivalents and restricted cash at end of period 19,803 57,619
Supplemental cash flow information:    
Cash paid for interest 22,317 28,709
Disclosure of non-cash investing and financing activities:    
Asset retirement obligations 707 1,308
Capital expenditures in accrued liabilities and accounts payable (7,526) (4,381)
Contract asset costs in accounts payable and accrued liabilities   4,753
Deemed dividends on Series A preferred stock $ 32,219 12,047
Accrued offering costs   $ (119)